Nick de Jonge
Nick de Jonge is currently working as a haematologist in the Amsterdam University Medical Center. His research focuses on appropiate use of antimicrobial therapy for fever during neutropaenia and identifying novel biomarkers to guide antibiotic treatment. He is member of the acute myeloid leukaemia (AML) scientific working group and member of the steering group for the European guideline about drug-drug interactions between antifungals and novel agents for AML.